Loading people...
Dr. Jeanne Bolger is a Venture Partner at Seroba Life Sciences and an independent board director based in Dublin, Ireland. Over a 35-year career in the pharmaceutical industry, she spent nearly a decade as Vice President of Venture Investments at Johnson & Johnson Innovation, following senior business development and clinical research roles at GlaxoSmithKline. She previously served as Global Head of Scientific Licensing for Johnson & Johnson’s pharmaceutical division and Vice President of Alliance Management at Janssen Alzheimer Immunotherapy. Bolger currently holds board positions at several European biotechnology companies, including serving as Chairperson of ExeVir and a director at Kingdom Therapeutics. She earned her medical degree from University College Dublin and serves as a visiting lecturer at Trinity College Dublin. Her current focus centers on venture capital investment, corporate governance, and clinical development for early-stage life sciences companies.
Dr. Jeanne Bolger stands as a pivotal figure in the European life sciences venture capital landscape, serving as a highly respected Venture Partner at Seroba Life Sciences. Seroba Life Sciences is renowned for its strategic investments in innovative European life science companies, and Dr. Bolger's expertise is instrumental in driving this mission forward. Her role involves identifying groundbreaking early-stage and growth-stage companies with the potential to revolutionize healthcare, guiding them through critical development phases, and ultimately bringing novel therapies and technologies to patients.
Jeanne's investment focus at Seroba Life Sciences spans a broad spectrum of the life sciences sector. She is particularly interested in companies developing cutting-edge solutions in biotechnology, pharmaceuticals, and medical technology. Her deep understanding of drug discovery, clinical development pathways, and regulatory landscapes allows her to evaluate opportunities with a discerning eye, ensuring that Seroba invests in ventures with robust scientific foundations and clear market potential. She also actively supports portfolio companies in navigating complex clinical trials, securing regulatory approvals, and formulating effective commercialization strategies.
Dr. Bolger's impressive career background provides a unique blend of medical insight and extensive industry experience. A qualified medical doctor, she brings a patient-centric perspective to her investment decisions. Prior to joining Seroba Life Sciences, Jeanne held senior leadership positions at several global pharmaceutical giants, including Pfizer, Amgen, and GSK. Notably, she also served as Vice President of New Business Development at Johnson & Johnson Innovation, where she was responsible for forging strategic partnerships and identifying disruptive technologies. This rich history in both clinical practice and corporate innovation equips her with an unparalleled ability to assess scientific merit, market viability, and operational challenges faced by life science startups.
Throughout her tenure, Dr. Bolger has been actively involved in shaping the trajectory of numerous promising companies. While specific investment details are often proprietary, her contributions are evident through her board positions at various Seroba portfolio companies, such as Inotrem, Complement Therapeutics, and Adcendo. In these roles, she provides invaluable strategic oversight, helping companies refine their scientific strategies, accelerate clinical programs, and prepare for successful market entry. Her guidance is crucial in transforming innovative research into tangible healthcare solutions, solidifying her reputation as a key enabler of progress in the life sciences investment community.
Jeanne Bolger is a distinguished Venture Partner at Seroba Life Sciences, a leading European life sciences venture capital firm. She is also a qualified medical doctor with extensive experience in the pharmaceutical industry.
Jeanne Bolger primarily invests in innovative early-stage and growth-stage companies within the life sciences sector, focusing on biotechnology, pharmaceuticals, and medical technology.
Jeanne Bolger works as a Venture Partner at Seroba Life Sciences, a prominent European venture capital firm specializing in life sciences investments.
